Is brain lactate increased in Huntington's disease?

Journal of the Neurological Sciences

Volumn 263, Issue 1-2, 2007, Pages 70-74

  Martin, W R Wayne ^a   Wieler, Marguerite ^a   Hanstock, Christopher C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Energy metabolism; Huntington's disease; Lactate; Magnetic resonance spectroscopy; Mitochondrial function

Indexed keywords

CREATININE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FEMALE; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; MALE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; STATISTICAL SIGNIFICANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; HUMANS; HUNTINGTON DISEASE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 35649013819     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.05.035     Document Type: Article

References (23)

1. Vonsattel J.-P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44 (1985) 559-577
2. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
3. Brennan W.A., Bird E.D., and Aprille J.R. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 44 (1985) 1948-1950
4. Mann V.M., Cooper J.M., Javoy-Agid F., Agid Y., Jenner P., and Schapira A.H. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336 (1990) 749
5. Parker W.D., Boyson S.J., Luder A.S., and Parks J.K. Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40 (1990) 1231-1234
6. Ludolph A.C., Seelig M.O., Ludolph A., et al. 3-nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration 1 (1992) 21-28
7. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., and Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61 (1993) 1147-1150
8. Beal M.F., Swartz K.J., Hyman B.T., et al. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism. J Neurochem 57 (1991) 1068-1073
9. Jenkins B.G., Koroshetz W.J., Beal M.F., and Rosen B.R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43 (1993) 2689-2695
10. Hoang T.Q., Bluml S., Dubowitz D.J., et al. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 50 (1998) 1033-1040
11. Huntington Study Group. The Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 11 (1996) 136-142
12. Shoulson I., and Fahn S. Huntington's disease: clinical care and evaluation. Neurology 29 (1979) 1-3
13. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29 (1993) 804-811
14. Hoult D.I., and Richards R.E. Critical factors in design of sensitive high-resolution nuclear magnetic-resonance spectrometers. Proc R Soc Lond A 344 (1975) 311-340
15. Hanstock C.C., and Allen P.S. Segmentation of brain from a PRESS localised single volume using double inversion recovery for simultaneous T1 nulling. Proceedings of the Society of Magnetic Resonance in Medicine (2000) 1964
16. Sharp N.H., Love S.J., Schilling G., et al. Widespread expression of the Huntington's disease gene (IT-15) protein product. Neuron 14 (1995) 1065-1074
17. Sapp E., Schwarz C., Chae K., et al. Huntington localization in brains of normal and Huntington's disease patients. Ann Neurol 42 (1997) 604-612
18. Martin W.R.W., Ye F.Q., and Allen P.S. Increasing striatal iron content associated with normal aging. Mov Disord 13 (1998) 281-286
19. Garseth M., Sonnewald U., White L.R., et al. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease. J Neurosci Res 60 (2000) 779-782
20. Nicoli F., Vion-Dury J., Maloteaux J.M., et al. CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 154 (1993) 47-51
21. Hanstock C.C., Rothman D.L., Prichard J.W., Jue T., and Shulman R.G. Spatially localised 1H NMR of metabolites in the human brain. Proc Natl Acad Sci U S A 85 (1988) 1821-1825
22. Harms L., Meierkord H., Timm G., Pfeiffer L., and Ludolph A.C. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 62 (1997) 27-30
23. Browne S.E., and Beal M.F. The energetics of Huntington's disease. Neurochem Res 29 (2004) 531-546